Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
161,813,505
-
Total 13F shares
-
122,927,880
-
Share change
-
+2,372,753
-
Total reported value
-
$4,901,945,988
-
Put/Call ratio
-
66%
-
Price per share
-
$39.89
-
Number of holders
-
316
-
Value change
-
+$74,001,388
-
Number of buys
-
154
-
Number of sells
-
166
Institutional Holders of IONIS PHARMACEUTICALS INC - Common Stock (IONS) as of Q2 2021
As of 30 Jun 2021 IONIS PHARMACEUTICALS INC - Common Stock (IONS) had 316 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 122,927,880 shares of stock of the company.
Largest 10 holders included FMR LLC, VANGUARD GROUP INC, PRICE T ROWE ASSOCIATES INC /MD/, Bellevue Group AG, ARK Investment Management LLC, BlackRock Inc., Clearbridge Investments, LLC, STATE STREET CORP, JPMORGAN CHASE & CO, and Camber Capital Management LP.
This table shows 320 institutional shareholders of the security as of 30 Jun 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.